novel coronavirus infection
Conditions
Interventions
Treatment group:Oral compound Lingzhi Anshen oral liquid + routine treatment
Control Group:routine treatment
Sponsors
Taizhou Enze Medical Center (Group) Enze Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. The convalescent patients with Covid-19 infection; 2. Aged 18-85 years old (including the cut-off value) , and the sex was not limited; 3. The patients accepted the treatment voluntarily and signed the informed consent. 4. BFI score >= 4 or Athens insomnia scale score >= 7
Exclusion criteria
Exclusion criteria: 1. The patients whose condition is not stable, 2. The patients whose consciousness is not clear, who have disturbance of consciousness, dementia, who can not understand the contents of the scale and check up and all kinds of psychosis, 3. The pregnant and lactating women; Women of childbearing age who were unable or unwilling to use adequate contraception during the trial or their spouses who were unwilling to use contraception; 4. Patients receiving oral or injection of Erythropoietin, hypnotic drugs, melatonin, or other Chinese patent medicines (pcms) 5. Patients who are participating in clinical trials of other drugs, and who are known to be allergic to therapeutic drugs; 6. The researcher judges that the patient is not suitable to participate in the study according to the clinical situation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fatigue;sleep quality; | — |
Secondary
| Measure | Time frame |
|---|---|
| life of quality ;Hemoglobin;Interleukin-6; | — |
Countries
China
Contacts
Public ContactXiaomai Wu
Taizhou Enze Medical Center (Group) Enze Hospital
Outcome results
None listed